Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1978 Apr;37(2):121–128. doi: 10.1136/ard.37.2.121

Systemic lupus erythematosus. A prospective analysis.

R Grigor, J Edmonds, R Lewkonia, B Bresnihan, G R Hughes
PMCID: PMC1001176  PMID: 646463

Abstract

The spectrum of organ involvement in 50 patients with systemic lupus erythematosus has been assessed in a prospective study. All patients were admitted to hospital electively for 2 days and a complete clinical and laboratory assessment protocol completed. Subsequent hospital admissions depended on clinical status. The overall mean observation period was 29 months. Widespread multisystem involvement was found in every patient. Subclinical abnormalities of respiratory and cerebral function were common even in patients in clinical remission. A more conservative approach than has been generally recommended was used for the management of systemic lupus erythematosus and is supported by the estimated 5-year survival of 98%.

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett R., Hughes G. R., Bywaters E. G., Holt P. J. Neuropsychiatric problems in systemic lupus erythematosus. Br Med J. 1972 Nov 11;4(5836):342–345. doi: 10.1136/bmj.4.5836.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bresnihan B., Bunn C., Snaith M. L., Hughes G. R. Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis. Br Med J. 1977 Mar 5;1(6061):610–611. doi: 10.1136/bmj.1.6061.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bresnihan B., Grigor R., Hughes G. R. Prospective analysis of antiribonucleoprotein antibodies in systemic lupus erythematosus. Ann Rheum Dis. 1977 Dec;36(6):557–559. doi: 10.1136/ard.36.6.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dubois E. L., Wierzchowiecki M., Cox M. B., Weiner J. M. Duration and death in systemic lupus erythematosus. An analysis of 249 cases. JAMA. 1974 Mar 25;227(12):1399–1402. [PubMed] [Google Scholar]
  5. Estes D., Christian C. L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971 Mar;50(2):85–95. doi: 10.1097/00005792-197103000-00001. [DOI] [PubMed] [Google Scholar]
  6. Fries J. F., Weyl S., Holman H. R. Estimating prognosis in systemic lupus erythematosus. Am J Med. 1974 Oct;57(4):561–565. doi: 10.1016/0002-9343(74)90007-2. [DOI] [PubMed] [Google Scholar]
  7. Grigor R. R., Shervington P. C., Hughes G. R., Hawkins D. F. Outcome of pregnancy in systemic lupus erythematosus. Proc R Soc Med. 1977 Feb;70(2):99–100. doi: 10.1177/003591577707000214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOLBOROW E. J., WEIR D. M., JOHNSON G. D. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J. 1957 Sep 28;2(5047):732–734. doi: 10.1136/bmj.2.5047.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KELLUM R. E., HASERICK J. R. SYSTEMIC LUPUS ERYTHEMATOSUS. A STATISTICAL EVALUATION OF MORTALITY BASED ON A CONSECUTIVE SERIES OF 299 PATIENTS. Arch Intern Med. 1964 Feb;113:200–207. doi: 10.1001/archinte.1964.00280080036008. [DOI] [PubMed] [Google Scholar]
  10. Kurata N., Tan E. M. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum. 1976 May-Jun;19(3):574–580. doi: 10.1002/art.1780190309. [DOI] [PubMed] [Google Scholar]
  11. Lee P., Urowitz M. B., Bookman A. A., Koehler B. E., Smythe H. A., Gordon D. A., Ogryzlo M. A. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977 Jan;46(181):1–32. [PubMed] [Google Scholar]
  12. MERRELL M., SHULMAN L. E. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis. 1955 Jan;1(1):12–32. doi: 10.1016/0021-9681(55)90018-7. [DOI] [PubMed] [Google Scholar]
  13. NOVOTNY H. R., ALVIS D. L. A method of photographing fluorescence in circulating blood in the human retina. Circulation. 1961 Jul;24:82–86. doi: 10.1161/01.cir.24.1.82. [DOI] [PubMed] [Google Scholar]
  14. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  15. Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 Feb;52(2):148–159. doi: 10.1016/0002-9343(72)90064-2. [DOI] [PubMed] [Google Scholar]
  16. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES